Peripheral Artery DiseaseSymptoms, Doctors, Treatments, Advances & More
Peripheral Artery Disease Overview
Learn About Peripheral Artery Disease
Duke Cardiology Arringdon
Manesh Patel is a Cardiologist practicing medicine in Morrisville, North Carolina. Dr. Patel is rated as an Elite provider by MediFind in the treatment of Peripheral Artery Disease. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Peripheral Artery Disease, Atherosclerosis, Coronary Heart Disease, Percutaneous Coronary Intervention (PCI), and Angioplasty. Dr. Patel is board certified in American Board Of Internal Med, Interventional Cardiology and American Board Of Internal Med, Cardiovascular Disease . Dr. Patel is currently accepting new patients.
Corewell Health Vascular Surgery - 275 Michigan St NE
Vikram Kashyap is a Vascular Surgeon practicing medicine in Grand Rapids, Michigan. Dr. Kashyap is rated as an Elite provider by MediFind in the treatment of Peripheral Artery Disease. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Carotid Artery Disease, Peripheral Artery Disease, Thoracic Aortic Aneurysm, Carotid Artery Surgery, and Stent Placement. Dr. Kashyap is board certified in American Board Of Surgery. Dr. Kashyap is currently accepting new patients.
University Hospitals
Mehdi Shishehbor is a Cardiologist practicing medicine in Cleveland,, Ohio. Dr. Shishehbor is rated as an Elite provider by MediFind in the treatment of Peripheral Artery Disease. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Peripheral Artery Disease, Atherosclerosis, Arterial Insufficiency, Angioplasty, and Atherectomy. Dr. Shishehbor is currently accepting new patients.
Summary: The purpose of this study is to evaluate the effect and safety of orforglipron once daily in participants with Fontaine II peripheral arterial disease (PAD). Participation in the study will last about 58 weeks.
Summary: The study aims to conduct a randomized controlled trial among adults aged 19 years or older who have experienced acute myocardial infarction at least one year prior, or who have other comorbidities such as peripheral arterial disease or multiple cardiovascular diseases, and have consented to participate in the study. Participants will be randomly assigned to either a group that maintains antiplate...

